CH +41 43 215 2361‬  /  UK +44 20 3855 4069‬  /  US +1 781 222 4779‬

Cogience. LifeSciences

We help our clients to solve the economic challenges of modern healthcare by identifying, developing and commercialising cost effective treatments to improve patients health related quality of life.

We specialize in

  • Pricing Reimbursement
  • Market Access
  • Health Economics
  • Outcomes Research
  • Asset Evaluation
  • Due Diligence

Unique Skills and Experience

With expertise in Pharmaceuticals, Biotechnology and Medical Devices we are able to leverage the knowledge, tools and best practices across industries.

Join our team

We are always looking for talented

people to join our team.

Check out our recruitment page

on our talent management site.

Our Value Proposition

We help our clients to solve the economic challenges of modern healthcare by identifying, developing and commercialising cost effective treatments to improve patients health related quality of life.

Pricing

Global and regional pricing strategies

Market Access

Refeference pricing and launch strategies

Health Economics

Global Value Dossiers and HTA advisory

Outcomes Research

Testing and evaluation of ecnomic models

Asset Evaluation

Global value propositions and product valuations

Due Diligence

Comprehensive due diligence reviews and documentation

Global Partner Network

With a global reach and unrivalled expertise, we are uniquely placed to help clients to create and maximise the value of their assets through commercially focussed market access strategies

Our Service Offering

Pricing Reimbursement and Market Access

Strategy Development Strategy Implementation
Develop global and regional pricing strategy Bespoke IRP database and tracking systems
Qualitative and quantitative research Local country / regional dossier preparation
Therapeutic area Payer Advisory boards Management of local reimbursement processes
International Reference Pricing (IRP) and launch strategy Stakeholder and influencer mapping
Individual case study and benchmark analysis KoL development
Secondary market research using data analysis Patient advocacy

Health Economics and Outcomes Research

  • Burden of illness study
  • Cost-effectiveness evaluation
  • Global Value Dossier
  • Clinical trial design to maximise value of asset
  • Observational studies
  • Testing and evaluation of economic models
  • Health Technology Assessment (HTA) advisory boards

Asset Evaluation and Due Diligence

  • Competitive landscape assessment
  • Global value proposition
  • Product valuations for out-licensing
  • Comprehensive due diligence documentation